Financhill
Back

Keros Therapeutics Quote, Financials, Valuation and Earnings

Keros Therapeutics Price Quote

$17.04
+0.01 (+0.71%)
(Updated: December 21, 2024 at 5:34 AM ET)

Keros Therapeutics Key Stats

Sell
4
Keros Therapeutics (KROS) is a Sell

Day range:
$16.62 - $17.64
52-week range:
$15.67 - $73.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
912.41
P/B ratio:
1.29%

Volume:
1.5M
Avg. volume:
1.3M
1-year change:
-49.59%
Market cap:
$689.8M
Revenue:
$151K
EPS:
$-5.21

How Much Does Keros Therapeutics Make?

Data Unavailable

Is Keros Therapeutics Growing As A Company?

Data Unavailable

Keros Therapeutics Stock Price Performance

What Is Keros Therapeutics 52-Week High & Low?

Keros Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Keros Therapeutics?

Data Unavailable

Is Keros Therapeutics Cash Flow Positive?

Data Unavailable

Keros Therapeutics Return On Invested Capital

Data Unavailable

Keros Therapeutics Earnings Date & Stock Price

Keros Therapeutics Competitors

  • Who Are Keros Therapeutics's Competitors?
    Below is a list of companies who compete with Keros Therapeutics or are related in some way:
    • Aptevo Therapeutics Inc (APVO)
    • Corcept Therapeutics Inc (CORT)
    • Regeneron Pharmaceuticals Inc (REGN)
    • Scholar Rock Holding Corp (SRRK)
    • Trevi Therapeutics Inc (TRVI)

Keros Therapeutics Dividend Yield

Data Unavailable

Keros Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -10.52%
Revenue: 4750% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable